OBJECTIVES: This study was undertaken to determine the prevalence of sexually transmitted diseases (STDs) in pregnant women in rural South Africa and to determine the value of using abnormal urogenital symptoms to identify infected women. METHODS: This was a cross-sectional study of 327 patients attending prenatal clinics. RESULTS: Of the 271 women with complete data, 141 (52%) had at least 1 STD and 49 (18%) had more than 1. Abnormal symptoms were common (n = 225; 83%), but associations were weak, and the positive predictive value of different symptoms for infection ranged from 2% to 54%. CONCLUSIONS: Most STDs in rural South African women remain undetected and untreated. As the scope for laboratory diagnosis in resource-poor settings is limited, presumptive treatment of pregnant women and their partners may be a cost-effective option to reduce transmission of STDs and HIV infection.
OBJECTIVES: This study was undertaken to determine the prevalence of sexually transmitted diseases (STDs) in pregnant women in rural South Africa and to determine the value of using abnormal urogenital symptoms to identify infected women. METHODS: This was a cross-sectional study of 327 patients attending prenatal clinics. RESULTS: Of the 271 women with complete data, 141 (52%) had at least 1 STD and 49 (18%) had more than 1. Abnormal symptoms were common (n = 225; 83%), but associations were weak, and the positive predictive value of different symptoms for infection ranged from 2% to 54%. CONCLUSIONS: Most STDs in rural South African women remain undetected and untreated. As the scope for laboratory diagnosis in resource-poor settings is limited, presumptive treatment of pregnant women and their partners may be a cost-effective option to reduce transmission of STDs and HIV infection.
Authors: P Mayaud; H Grosskurth; J Changalucha; J Todd; B West; R Gabone; K Senkoro; M Rusizoka; M Laga; R Hayes Journal: Bull World Health Organ Date: 1995 Impact factor: 9.408
Authors: B Vuylsteke; M Laga; M Alary; M M Gerniers; J P Lebughe; N Nzila; F Behets; E Van Dyck; P Piot Journal: Clin Infect Dis Date: 1993-07 Impact factor: 9.079
Authors: O Steingrímsson; J H Olafsson; H Thórarinsson; R W Ryan; R B Johnson; R C Tilton Journal: Sex Transm Dis Date: 1994 Jan-Feb Impact factor: 2.830
Authors: H Grosskurth; F Mosha; J Todd; E Mwijarubi; A Klokke; K Senkoro; P Mayaud; J Changalucha; A Nicoll; G ka-Gina Journal: Lancet Date: 1995-08-26 Impact factor: 79.321
Authors: S Aboud; G Msamanga; J S Read; A Mwatha; Y Q Chen; D Potter; M Valentine; U Sharma; I Hoffmann; T E Taha; R L Goldenberg; W W Fawzi Journal: Int J STD AIDS Date: 2008-12 Impact factor: 1.359
Authors: Ranmini S Kularatne; Ronelle Niit; Jane Rowley; Tendesayi Kufa-Chakezha; Remco P H Peters; Melanie M Taylor; Leigh F Johnson; Eline L Korenromp Journal: PLoS One Date: 2018-10-15 Impact factor: 3.240
Authors: Navjyot K Vidwan; Annie Regi; Mark Steinhoff; Jill S Huppert; Mary Allen Staat; Caitlin Dodd; Rida Nongrum; Shalini Anandan; Valsan Verghese Journal: PLoS One Date: 2012-05-02 Impact factor: 3.240
Authors: R G White; P Moodley; N McGrath; V Hosegood; B Zaba; K Herbst; M Newell; W A Sturm; R J Hayes Journal: Sex Transm Infect Date: 2008-08-15 Impact factor: 3.519